200 10510 design:1.14971829960161 draw:1.80971327284465 figure:1.80971327284465 gonna:3.55891312765391 lorelei:4.53974238066564 mucci:4.25206030821386 researchers:1.94947521521981 study:0.59204083473787 talk:0.42341891172476 thought:1.92478260262944
10510 19410 cohort:1.16101785485554 design:1.14971829960161 eric:4.53974238066564 follow:1.02323415249249 health:1.34789522818535 professionals:3.44113009199753 rimm:4.53974238066564 study:0.59204083473787 talked:0.42341891172476
19410 29640 case:0.325148690291958 cohort:1.16101785485554 control:0.919855798038651 levels:1.07400647786591 nested:2.93030446823154 researchers:1.94947521521981 risk:0.614474148487469 selenium:3.84659520010569 study:0.59204083473787 undertook:4.53974238066564
29640 36700 advanced:3.55891312765391 cancer:1.54401010711165 follow:1.02323415249249 health:1.34789522818535 professionals:3.44113009199753 prostate:3.84659520010569 remember:0.417998844255421 started:0.748005541111992 study:0.296020417368935
36700 47020 men:2.38025813131226 50000:3.84659520010569 1986:1.36168855031769 invited:2.74798291143758
47020 57210 cancer:3.0880202142233 free:2.38025813131226 including:1.44869992730732 initially:2.27105883934727 men:2.72337710063538 prostate:3.84659520010569 men:0.748005541111992 started:0.296020417368935
57210 69030 collect:1.68711095075232 interesting:0.675510039073838 investigators:1.66806275578162 reason:0.834333624600489 source:2.54731221597543 thought:1.92478260262944 toenails:8.0578335137993 year:0.485063074835967
69030 77130 biomarkers:3.55891312765391 entire:1.94947521521981 nail:4.25206030821386 study:0.296020417368935 takes:0.859231176222216 year:0.485063074835967
77130 87530 beginning:1.51122028428865 biological:3.24045939653538 clipping:4.02891675689965 end:0.802072762382268 grow:3.15344801954575 levels:1.07400647786591 nail:4.25206030821386 part:1.0844777777332 study:0.296020417368935 taking:0.859231176222216
87530 97430 factors:0.90215622093925 happened:0.60791674794131 50000:1.36168855031769 previous:0.867670044868081 reflect:1.49521994294221 specimens:3.69244452027843 toenail:4.02891675689965 year:0.485063074835967
97430 105590 professionals:1.02323415249249 man:1.34789522818535 37000:2.74798291143758 health:3.44113009199753 follow:0.296020417368935 toenails:4.02891675689965
105590 114280 case:0.325148690291958 control:0.919855798038651 nested:2.93030446823154 population:0.514390689930487 source:2.54731221597543 study:0.296020417368935
114280 122890 author:3.24045939653538 back:0.244727122981384 ed:4.9452074887738 giovannucci:4.9452074887738 hypothesis:1.26890681686672 study:0.296020417368935
122890 132510 clark:7.69319040021138 hypothesis:1.26890681686672 larry:9.8904149775476 randomized:1.17244655067916 referred:1.38985942728439 study:0.59204083473787 trial:1.54401010711165
132510 139200 1996:4.9452074887738 1996:1.26890681686672 published:2.38025813131226 ed:0.296020417368935
139200 147090 back:0.244727122981384 collection:1.68711095075232 toenails:4.02891675689965
147090 156820 funds:3.84659520010569 limited:1.66806275578162 measure:0.396607654274103 selenium:3.84659520010569 stored:2.99929733971849 study:0.296020417368935 toenails:4.02891675689965 wanted:0.956223442209526
156820 165550 nested:0.325148690291958 case:0.919855798038651 levels:1.07400647786591 measure:0.396607654274103 37000:1.36168855031769 undertook:2.93030446823154 selenium:3.84659520010569 control:0.296020417368935 men:4.53974238066564
165550 174130 ed:4.9452074887738 1996:0.802072762382268 ended:1.02323415249249 follow:0.296020417368935
174130 183460 advanced:3.55891312765391 basically:1.28164584264415 cancer:1.54401010711165 cases:0.325148690291958 occurred:1.57791165878733 prostate:3.84659520010569
183460 195230 advanced:3.55891312765391 cancer:1.54401010711165 cases:0.325148690291958 order:1.78820706762369 prostate:3.84659520010569 risk:0.614474148487469 sampling:0.668541369757745 select:1.44869992730732 set:0.37566448042886 undertook:4.53974238066564
195230 203070 case:0.325148690291958 controls:0.919855798038651 identified:1.83169217956343 means:0.526366880977203 remember:0.417998844255421 risk:0.614474148487469 set:0.37566448042886 study:0.296020417368935
203070 212740 prostate:1.54401010711165 risk:0.87618073453599 1988:0.810040932031445 looked:1.36168855031769 number:0.153557735843091 developing:3.84659520010569 men:0.614474148487469 cancer:0.0700101655726489
212740 223500 case:0.325148690291958 control:1.8397115960773 men:1.34789522818535 37000:1.36168855031769 nested:5.86060893646308 health:3.44113009199753 risk:0.614474148487469 sampling:0.668541369757745 selected:1.44869992730732 set:0.37566448042886 study:0.296020417368935
223500 236090 compare:0.634408363388287 epidemiological:2.41947884446554 find:0.778542264972074 follow:1.02323415249249 researchers:1.94947521521981 results:0.634408363388287 specimen:3.69244452027843 study:0.59204083473787 toenail:4.02891675689965
236090 247620 cancer:1.54401010711165 clark:3.84659520010569 found:1.76715365842585 health:1.34789522818535 larry:4.9452074887738 melanoma:4.53974238066564 men:1.36168855031769 population:0.514390689930487 professionals:3.44113009199753 randomized:1.17244655067916 skin:3.69244452027843 source:2.54731221597543 study:0.296020417368935 trial:1.54401010711165
247620 257190 follow:0.325148690291958 years:1.02323415249249 selenium:1.07400647786591 toenails:0.396607654274103 33000:1.36168855031769 measured:3.84659520010569 men:8.0578335137993 toenails:0.485063074835967
257190 267320 advanced:3.55891312765391 calculate:0.550758334101362 cancer:1.54401010711165 controls:0.919855798038651 develop:0.87618073453599 follow:1.02323415249249 measure:0.396607654274103 men:1.36168855031769 number:0.153557735843091 odds:0.984394319176222 prostate:3.84659520010569 ratios:0.654748047625409 years:0.485063074835967
267320 274870 found:1.76715365842585 highest:3.15344801954575 levels:1.07400647786591 men:1.36168855031769 relative:2.34251780332942 risk:0.614474148487469 selenium:3.84659520010569
274870 284230 developing:3.55891312765391 prostate:1.54401010711165 cancer:0.634408363388287 risk:0.87618073453599 lowest:1.07400647786591 60:1.47947158597407 men:3.44113009199753 compared:1.36168855031769 advanced:3.84659520010569 lower:0.614474148487469 toenails:4.02891675689965
284230 296750 chance:1.14971829960161 estimate:0.748005541111992 line:0.984394319176222 paper:1.7263316639056 randomized:1.17244655067916 read:1.52748080516043 relative:2.34251780332942 results:0.634408363388287 risk:0.614474148487469 trial:1.54401010711165
296750 306230 critiquing:3.44113009199753 detail:2.11199414471758 questions:0.520360856916991 study:0.296020417368935 talk:0.42341891172476 thinking:1.83169217956343
306230 318390 authors:3.24045939653538 case:0.325148690291958 cohort:2.32203570971108 conducted:2.54731221597543 control:0.919855798038651 cohort:2.69391569016731 nested:2.93030446823154 question:0.520360856916991 study:0.59204083473787
318390 330160 address:2.14184710786727 bit:0.550758334101362 complex:2.4603008389858 principles:2.80514132527753 question:1.04072171383398 risk:0.614474148487469 sampling:0.668541369757745 set:0.37566448042886
330160 337400 advanced:3.55891312765391 cancer:1.54401010711165 case:0.325148690291958 design:1.14971829960161 identified:1.83169217956343 prostate:3.84659520010569 researchers:1.94947521521981
337400 347000 case:0.325148690291958 control:0.919855798038651 definition:1.68711095075232 population:0.514390689930487 risk:1.22894829697494 sampled:1.33708273951549 set:0.37566448042886 source:2.54731221597543
347000 358580 advanced:3.55891312765391 cancer:1.54401010711165 diagnosed:1.66806275578162 discuss:1.9747930232041 participant:1.92478260262944 prostate:3.84659520010569 question:0.520360856916991
358580 367760 cancer:1.54401010711165 diagnosed:3.33612551156324 participants:1.92478260262944 prostate:3.84659520010569 1993:0.520360856916991
367760 377090 control:0.919855798038651 exclude:2.86576594709396 number:0.153557735843091 participant:3.84956520525888 potential:1.47947158597407 risk:0.614474148487469 set:0.37566448042886
377090 386180 control:0.919855798038651 exclude:2.86576594709396 person:0.582108863985438 potential:1.47947158597407 question:0.520360856916991
386180 394540 case:0.325148690291958 diagnosed:1.66806275578162 relates:0.396607654274103 1990:1.04072171383398 question:1.28164584264415
394540 406140 exposure:2.58909849496012 oftentimes:4.9452074887738 selenium:3.84659520010569 simply:2.59383223161032 study:0.296020417368935 things:0.209009040379305
406140 416420 case:0.325148690291958 categorize:2.59383223161032 complicated:2.59383223161032 exposure:1.29454924748006 oftentimes:4.9452074887738 question:0.520360856916991 yesno:4.25206030821386
416420 425640 continuous:1.49521994294221 divided:0.725699783597694 equal:0.462204936759917 exposure:1.29454924748006 groups:0.249282939517245 measure:0.396607654274103 quintiles:4.53974238066564 study:0.296020417368935 window:2.38025813131226
425640 436160 years:1.70652903660942 happened:0.60791674794131 levels:1.07400647786591 measurement:0.396607654274103 reflect:1.49521994294221 selenium:7.69319040021138 20:0.485063074835967
436160 445830 findings:0.778542264972074 influence:1.94947521521981 interpretation:1.52748080516043 recently:3.07340531187221 reflect:1.49521994294221 study:0.296020417368935
445830 453870 biases:2.64262239577975 exposure:1.29454924748006 limitations:1.66806275578162 measurement:0.396607654274103 potential:1.47947158597407
453870 461980 concepts:1.92478260262944 core:4.25206030821386 epidemiology:1.43366204994278 exposure:1.29454924748006 measurement:0.396607654274103 relate:1.28164584264415
461980 471150 bias:3.9495860464082 concerned:2.08300660784433 estimate:0.748005541111992 finally:1.21951406153715 influence:1.94947521521981 relative:2.34251780332942 risk:0.614474148487469
471150 478990 bias:1.9747930232041 gonna:3.55891312765391 great:2.34251780332942 influence:1.94947521521981 potential:1.47947158597407 question:0.520360856916991
478990 489410 compare:0.634408363388287 contrast:3.3357695763397 final:1.21951406153715 question:0.520360856916991 relates:1.28164584264415 study:0.296020417368935 subsequent:3.07340531187221 undertaken:4.53974238066564
489410 500950 secondary:1.14971829960161 clark:3.84659520010569 1996:1.76715365842585 larry:4.9452074887738 analysis:1.36168855031769 published:2.38025813131226 randomized:2.34489310135832 found:4.02891675689965 study:0.59204083473787
500950 510390 prostate:1.54401010711165 cancer:0.634408363388287 placebo:2.41947884446554 60:1.47947158597407 compared:1.36168855031769 randomized:2.5028604534046 risk:3.84659520010569 men:1.17244655067916 lower:0.614474148487469 selenium:3.84659520010569 epidemiological:0.296020417368935
510390 518559 biomarkers:3.55891312765391 blood:1.40424816473649 selenium:3.84659520010569 studies:0.296020417368935 toenails:4.02891675689965 undertaken:4.53974238066564
518558 528770 advanced:3.55891312765391 association:1.11656609228471 cancer:3.0880202142233 found:1.76715365842585 inverse:2.99929733971849 levels:1.07400647786591 prostate:7.69319040021138 risk:1.22894829697494 selenium:3.84659520010569
528770 538130 ago:1.70652903660942 cancer:1.54401010711165 institute:3.3357695763397 national:2.4603008389858 select:1.44869992730732 study:0.296020417368935 trial:1.54401010711165 undertook:4.53974238066564 years:0.485063074835967
538130 547130 based:1.00362568110411 conducted:2.54731221597543 data:0.231182897873627 epidemiological:2.41947884446554 prostate:3.84659520010569 select:1.44869992730732 selenium:3.84659520010569 specifically:1.29454924748006 trail:4.9452074887738 undertaken:4.53974238066564
547130 555620 agent:2.93030446823154 cancer:3.0880202142233 chemo:4.9452074887738 potential:1.47947158597407 preventive:5.18766446322064 primary:2.38025813131226 prostate:3.84659520010569 selenium:3.84659520010569 thinking:1.83169217956343
555620 567450 randomized:0.281768394661733 healthy:1.54401010711165 factorial:1.14971829960161 time:2.64262239577975 called:3.44113009199753 states:2.64262239577975 35000:1.36168855031769 diagnosis:1.17244655067916 recruited:3.07340531187221 united:1.41884696415764 cancer:0.0700101655726489 men:1.70652903660942
567450 576560 placebo:2.5028604534046 received:1.87715455364018 selenium:7.69319040021138 vitamin:5.99859467943698
576560 587100 average:2.1689555554664 contrast:3.3357695763397 epidemiological:2.41947884446554 follow:1.02323415249249 published:2.38025813131226 study:0.888061252106805 years:0.485063074835967
587100 597810 association:1.11656609228471 cancer:1.54401010711165 clark:3.84659520010569 found:1.76715365842585 larry:4.9452074887738 prostate:3.84659520010569 randomization:1.17244655067916 results:0.634408363388287 risk:0.614474148487469 selenium:3.84659520010569 study:0.296020417368935
597810 605880 protective:0.96552583487184 found:1.87715455364018 104:1.76715365842585 evidence:3.07340531187221 relative:2.34251780332942 risk:0.614474148487469 effect:3.84659520010569
605880 614110 cancer:1.54401010711165 guess:2.64262239577975 prevention:2.59383223161032 prostate:3.84659520010569 question:0.520360856916991 supplementation:3.69244452027843
614110 623410 advantages:2.02743675668952 compared:0.634408363388287 control:0.919855798038651 disadvantages:2.99929733971849 epidemiological:2.41947884446554 question:0.520360856916991 randomized:1.17244655067916 study:0.296020417368935 trial:1.54401010711165
623410 635200 bias:1.9747930232041 concerned:2.08300660784433 confounding:1.36168855031769 explanations:2.38025813131226 exposure:1.29454924748006 interpretation:1.52748080516043 outcomes:0.654748047625409 plausible:3.44113009199753 randomized:1.17244655067916
635200 644760 answers:0.538488241509547 comparison:1.9747930232041 controlled:0.919855798038651 critique:3.44113009199753 epidemiological:2.41947884446554 final:1.21951406153715 forward:2.30615015915854 post:2.86576594709396 question:0.520360856916991 study:0.888061252106805
644760 654100 comments:2.86576594709396 critique:3.44113009199753 letting:3.24045939653538 logging:2.34251780332942 part:1.0844777777332 providing:2.05483573087764 questions:0.520360856916991 thoughts:1.92478260262944
